CDKN2A and central nervous system neoplasm: CDKN2A/B homozygous deletions were previously identified as a negative prognostic factor in IDH-mutant astrocytomas in update 5 of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.